PET/CT in radiation oncology

Medical Physics

Volumn 35, Issue 11, 2008, Pages 4955-4966

  Pan, Tinsu ^a,b   Mawlawi, Osama ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

4D CT; Average CT; Cine CT; MIP CT; PET CT

Indexed keywords

DIAGNOSIS; DISEASE CONTROL; DISEASES; ONCOLOGY; RADIOTHERAPY;

CANCER PATIENTS; CLINICAL OUTCOME; DISEASE TREATMENT; PATIENT COMFORT; PATIENT MANAGEMENT; PET/CT SCANNERS; RADIATION ONCOLOGISTS; RADIATION ONCOLOGY;

COMPUTERIZED TOMOGRAPHY;

BISMUTH GERMINATE OXIDE; FLUORINE 18; GADOLINIUM; GADOLINIUM OXYORTHOSILICATE; GLUCOSE; LUTETIUM; LUTETIUM OXYORTHOSILICATE; METAL OXIDE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; YTTRIUM;

ARTIFACT REDUCTION; BREAST CANCER; BREATHING PATTERN; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM CANCER; FOUR DIMENSIONAL IMAGING; GLUCOSE TRANSPORT; GLYCOLYSIS; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMAGE QUALITY; IMAGING SYSTEM; INTERMETHOD COMPARISON; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MELANOMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; ONCOLOGY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; THORAX; THREE DIMENSIONAL IMAGING; TUMOR CELL; TUMOR LOCALIZATION; TUMOR SCINTISCANNING; TWO DIMENSIONAL IMAGING;

EID: 54949133372     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2986145     Document Type: Review

References (140)

1. T. Beyer, D. W. Townsend, T. Brun, P. E. Kinahan, M. Charron, R. Roddy, J. Jerin, J. Young, L. Byars, and R. Nutt, " A combined PET/CT scanner for clinical oncology.," J. Nucl. Med. 41, 1369-1379 (2000).
2. D. W. Townsend and T. Beyer, " A combined PET/CT scanner: The path to true image fusion.," Br. J. Radiol. 75, S24-S30 (2002).
3. B. F. Hutton and M. Braun, " Software for image registration: Algorithms, accuracy, efficacy.," Semin Nucl. Med. 33, 180-192 (2003).
4. J. West, " Comparison and evaluation of retrospective intermodality brain image registration techniques.," J. Comput. Assist. Tomogr. 21, 554-566 (1997).
5. D. W. Townsend, " Positron emission tomography/computed tomography.," Semin Nucl. Med. 38, 152-166 (2008).
6. R. L. Wahl, L. E. Quint, R. D. Cieslak, A. M. Aisen, R. A. Koeppe, and C. R. Meyer, " 'Anatometabolic' tumor imaging: Fusion of FDG PET with CT or MRI to localize foci of increased activity.," J. Nucl. Med. 34, 1190-1197 (1993).
7. P. Reinartz, F. J. Wieres, W. Schneider, A. Schur, and U. Buell, " Side-by-side reading of PET and CT scans in oncology: Which patients might profit from integrated PET/CT?," Eur. J. Nucl. Med. Mol. Imaging 31, 1456-1461 (2004).
8. E. M. Rohren, T. G. Turkington, and R. E. Coleman, " Clinical applications of PET in oncology.," Radiology 231, 305-332 (2004).
9. S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. Silverman, R. E. Coleman, and M. E. Phelps, " A tabulated summary of the FDG PET literature.," J. Nucl. Med. 42, 1S-93S (2001).
10. P. G. Kluetz, C. C. Meltzer, V. L. Villemagne, P. E. Kinahan, S. Chander, M. A. Martinelli, and D. W. Townsend, " Combined PET/CT imaging in oncology. Impact on patient management.," Clin Positron Imaging 3, 223-230 (2000).
11. T. F. Hany, H. C. Steinert, G. W. Goerres, A. Buck, and G. K. von Schulthess, " PET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results.," Radiology 225, 575-581 (2002).
12. R. Bar-Shalom, N. Yefremov, L. Guralnik, D. Gaitini, A. Frenkel, A. Kuten, H. Altman, Z. Keidar, and O. Israel, " Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management.," J. Nucl. Med. 44, 1200-1209 (2003).
13. D. Lardinois, W. Weder, T. F. Hany, E. M. Kamel, S. Korom, B. Seifert, G. K. von Schulthess, and H. C. Steinert, " Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.," N. Engl. J. Med. 348, 2500-2507 (2003).
14. V. Gregoire, K. Haustermans, X. Geets, S. Roels, and M. Lonneux, " PET-based treatment planning in radiotherapy: A new standard?," J. Nucl. Med., Suppl. 48, 68S-77S (2007).
15. F. Paulsen, J. Scheiderbauer, S. M. Eschmann, K. Brechtel, M. Klein, C. Pfannenberg, A. Mondry, T. Hehr, C. Belka, and M. Bamberg, " First experiences of radiation treatment planning with PET/CT.," Strahlenther. Onkol. 182, 369-375 (2006).
16. S. Rothschild, G. Studer, B. Seifert, P. Huguenin, C. Glanzmann, J. B. Davis, U. M. Lutolf, T. F. Hany, and I. F. Ciernik, " PET/CT staging followed by intensity-modulated radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: A matched-pair comparison.," Radiat. Oncol. Invest. June 2-22 (2007).
17. D. Wang, " Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.," Int. J. Radiat. Oncol., Biol., Phys. 65, 143-151 (2006).
18. A. C. Riegel, A. M. Berson, S. Destian, T. Ng, L. B. Tena, R. J. Mitnick, and P. S. Wong, " Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion.," Int. J. Radiat. Oncol., Biol., Phys. 65, 726-732 (2006).
19. I. F. Ciernik, E. Dizendorf, B. G. Baumert, B. Reiner, C. Burger, J. B. Davis, U. M. Lutolf, H. C. Steinert, and G. K. Von Schulthess, " Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study.," Int. J. Radiat. Oncol., Biol., Phys. 57, 853-863 (2003).
20. M. R. Vernon, M. Maheshwari, C. J. Schultz, M. A. Michel, S. J. Wong, B. H. Campbell, B. L. Massey, J. F. Wilson, and D. Wang, " Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.," Int. J. Radiat. Oncol., Biol., Phys. 70, 678-684 (2008).
21. H. Ashamalla, A. Guirgius, E. Bieniek, S. Rafla, A. Evola, G. Goswami, R. Oldroyd, B. Mokhtar, and K. Parikh, " The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers.," Int. J. Radiat. Oncol., Biol., Phys. 68, 388-395 (2007).
22. P. H. Ahn and M. K. Garg, " Positron emission tomography/computed tomography for target delineation in head and neck cancers.," Semin Nucl. Med. 38, 141-148 (2008).
23. B. Dietl and J. Marienhagen, " The therapeutic impact of (18)F-FDG whole body PET. A radiooncologist's view.," Nuklearmedizin 44, 8-14 (2005).
24. X. K. Zheng, L. H. Chen, Q. S. Wang, H. B. Wu, H. M. Wang, Y. Q. Chen, W. P. Yan, Q. S. Li, and Y. K. Xu, " Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.," Int. J. Radiat. Oncol., Biol., Phys. 69, 1381-1388 (2007).
25. R. H. Ireland, K. E. Dyker, D. C. Barber, S. M. Wood, M. B. Hanney, W. B. Tindale, N. Woodhouse, N. Hoggard, J. Conway, and M. H. Robinson, " Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT.," Int. J. Radiat. Oncol., Biol., Phys. 68, 952-957 (2007).
26. D. L. Schwartz, " FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation.," Head Neck 27, 478-487 (2005).
27. L. J. Vanuytsel, J. F. Vansteenkiste, S. G. Stroobants, P. R. De Leyn, W. De Wever, E. K. Verbeken, G. G. Gatti, D. P. Huyskens, and G. J. Kutcher, " The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.," Radiother. Oncol. 55, 317-324 (2000).
28. J. Y. Chang, L. Dong, H. Liu, G. Starkschall, P. Balter, R. Mohan, Z. Liao, J. D. Cox, and R. Komaki, " Image-guided radiation therapy for non-small cell lung cancer.," J. Thorac. Oncol. 3, 177-186 (2008).
29. H. Ashamalla, S. Rafla, K. Parikh, B. Mokhtar, G. Goswami, S. Kambam, H. Abdel-Dayem, A. Guirguis, P. Ross, and A. Evola, " The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.," Int. J. Radiat. Oncol., Biol., Phys. 63, 1016-1023 (2005).
30. E. Brianzoni, " Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume.," Eur. J. Nucl. Med. Mol. Imaging 32, 1392-1399 (2005).
31. D. De Ruysscher, " Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study.," Radiother. Oncol. 77, 5-10 (2005).
32. A. H. Klopp, J. Y. Chang, S. L. Tucker, E. P. Sulman, P. A. Balter, H. H. Liu, M. K. Bucci, H. A. Macapinlac, R. Komaki, and J. D. Cox, " Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation.," Int. J. Radiat. Oncol., Biol., Phys. 69, 1409-1416 (2007).
33. C. Greco, K. Rosenzweig, G. L. Cascini, and O. Tamburrini, " Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).," Lung Cancer 57, 125-134 (2007).
34. G. L. Ceresoli, G. M. Cattaneo, P. Castellone, G. Rizzos, C. Landoni, V. Gregorc, R. Calandrino, E. Villa, C. Messa, A. Santoro, and F. Fazio, " Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: A comparison with standard techniques with and without elective nodal irradiation.," Tubercle 93, 88-96 (2007).
35. U. Nestle, " 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis.," Int. J. Radiat. Oncol., Biol., Phys. 44, 593-597 (1999).
36. Y. E. Erdi, K. Rosenzweig, A. K. Erdi, H. A. Macapinlac, Y. C. Hu, L. E. Braban, J. L. Humm, O. D. Squire, C. S. Chui, S. M. Larson, and E. D. Yorke, " Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).," Radiother. Oncol. 62, 51-60 (2002).
37. J. Bradley, W. L. Thorstad, S. Mutic, T. R. Miller, F. Dehdashti, B. A. Siegel, W. Bosch, and R. J. Bertrand, " Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.," Int. J. Radiat. Oncol., Biol., Phys. 59, 78-86 (2004).
38. F. M. Kong, K. A. Frey, L. E. Quint, R. K. Ten Haken, J. A. Hayman, M. Kessler, I. J. Chetty, D. Normolle, A. Eisbruch, and T. S. Lawrence, " A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.," J. Clin. Oncol. 25, 3116-3123 (2007).
39. M. P. Mac Manus, R. J. Hicks, D. L. Ball, V. Kalff, J. P. Matthews, E. Salminen, P. Khaw, A. Wirth, D. Rischin, and A. McKenzie, " F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: Powerful correlation with survival and high impact on treatment.," Cancer 92, 886-895 (2001).
40. M. T. Munley, L. B. Marks, C. Scarfone, G. S. Sibley, E. F. Patz, Jr., T. G. Turkington, R. J. Jaszczak, D. R. Gilland, M. S. Anscher, and R. E. Coleman, " Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: Challenges and prospects.," Lung Cancer 23, 105-114 (1999).
41. E. C. Ford, W. C. Lavely, D. A. Frassica, L. T. Myers, F. Asrari, R. L. Wahl, and R. C. Zellars, " Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation.," Int. J. Radiat. Oncol., Biol., Phys. 71, 595-602 (2008).
42. C. Everitt and T. Leong, " Influence of F-fluorodeoxyglucose- positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer.," Australas Radiol. 50, 271-274 (2006).
43. T. Leong, " A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.," Radiother. Oncol. 78, 254-261 (2006).
44. M. Hutchings, A. Loft, M. Hansen, A. K. Berthelsen, and L. Specht, " Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma.," Eur. J. Haematol. 78, 206-212 (2007).
45. J. Esthappan, S. Chaudhari, L. Santanam, S. Mutic, J. Olsen, D. M. Macdonald, D. A. Low, A. K. Singh, and P. W. Grigsby, " Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes.," Int. J. Radiat. Oncol., Biol., Phys. (in press).
46. I. F. Ciernik, M. Huser, C. Burger, J. B. Davis, and G. Szekely, " Automated functional image-guided radiation treatment planning for rectal cancer.," Int. J. Radiat. Oncol., Biol., Phys. 62, 893-900 (2005).
47. D. A. Patel, S. T. Chang, K. A. Goodman, A. Quon, B. Thorndyke, S. S. Gambhir, A. McMillan, B. W. Loo, Jr., and A. C. Koong, " Impact of integrated PET/CT on variability of target volume delineation in rectal cancer.," Technol. Cancer Res. Treat. 6, 31-36 (2007).
48. I. F. Ciernik, D. W. Brown, D. Schmid, T. Hany, P. Egli, and J. B. Davis, " 3D-segmentation of the 18F-choline PET signal for target volume definition in radiation therapy of the prostate.," Technol. Cancer Res. Treat. 6, 23-30 (2007).
49. R. J. Steenbakkers, " Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis.," Int. J. Radiat. Oncol., Biol., Phys. 64, 435-448 (2006).
50. J. L. Fox, R. Rengan, W. O'Meara, E. Yorke, Y. Erdi, S. Nehmeh, S. A. Leibel, and K. E. Rosenzweig, " Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?," Int. J. Radiat. Oncol., Biol., Phys. 62, 70-75 (2005).
51. D. De Ruysscher, " Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study.," Int. J. Radiat. Oncol., Biol., Phys. 62, 988-994 (2005).
52. A. van Baardwijk, B. G. Baumert, G. Bosmans, M. van Kroonenburgh, S. Stroobants, V. Gregoire, P. Lambin, and D. De Ruysscher, " The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning.," Cancer Treat Res. 32, 245-260 (2006).
53. R. D. Stewart and X. A. Li, " BGRT: Biologically guided radiation therapy-The future is fast approaching.," Med. Phys. 34, 3739-3751 (2007).
54. C. C. Ling, J. Humm, S. Larson, H. Amols, Z. Fuks, S. Leibel, and J. A. Koutcher, " Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality.," Int. J. Radiat. Oncol., Biol., Phys. 47, 551-560 (2000).
55. C. C. Ling and X. A. Li, " Over the next decade the success of radiation treatment planning will be judged by the immediate biological response of tumor cells rather than by surrogate measures such as dose maximization and uniformity.," Med. Phys. 32, 2189-2192 (2005).
56. K. S. Chao, W. R. Bosch, S. Mutic, J. S. Lewis, F. Dehdashti, M. A. Mintun, J. F. Dempsey, C. A. Perez, J. A. Purdy, and M. J. Welch, " A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.," Int. J. Radiat. Oncol., Biol., Phys. 49, 1171-1182 (2001).
57. Z. Lin, J. Mechalakos, S. Nehmeh, H. Schoder, N. Lee, J. Humm, and C. C. Ling, " The influence of changes in tumor hypoxia on dose-painting treatment plans based on (18)F-FMISO positron emission tomography.," Int. J. Radiat. Oncol., Biol., Phys. 70, 1219-1228 (2008).
58. I. Serganova, J. Humm, C. Ling, and R. Blasberg, " Tumor hypoxia imaging.," Clin. Cancer Res. 12, 5260-5264 (2006).
59. K. Mah, C. B. Caldwell, Y. C. Ung, C. E. Danjoux, J. M. Balogh, S. N. Ganguli, L. E. Ehrlich, and R. Tirona, " The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study.," Int. J. Radiat. Oncol., Biol., Phys. 52, 339-350 (2002).
60. K. R. Zasadny and R. L. Wahl, " Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction.," Radiology 189, 847-850 (1993).
61. J. W. Keyes, Jr., " SUV: Standard uptake or silly useless value?," J. Nucl. Med. 36, 1836-1839 (1995).
62. G. W. Goerres, C. Burger, M. R. Schwitter, T. N. Heidelberg, B. Seifert, and G. K. von Schulthess, " PET/CT of the abdomen: Optimizing the patient breathing pattern.," Eur. Radiol. 13, 734-739 (2003).
63. T. Beyer, G. Antoch, T. Blodgett, L. F. Freudenberg, T. Akhurst, and S. Mueller, " Dual-modality PET/CT imaging: The effect of respiratory motion on combined image quality in clinical oncology.," Eur. J. Nucl. Med. Mol. Imaging 30, 588-596 (2003).
64. G. W. Goerres, C. Burger, E. Kamel, B. Seifert, A. H. Kaim, A. Buck, T. C. Buehler, and G. K. Von Schulthess, " Respiration-induced attenuation artifact at PET/CT: Technical considerations.," Radiology 226, 906-910 (2003).
65. T. Beyer, S. Rosenbaum, P. Veit, J. Stattaus, S. P. Muller, F. P. Difilippo, H. Schoder, O. Mawlawi, F. Roberts, A. Bockisch, and H. Kuhl, " Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows.," Eur. J. Nucl. Med. Mol. Imaging 32, 1429-1439 (2005).
66. G. W. Goerres, T. F. Hany, E. Kamel, G. K. von Schulthess, and A. Buck, " Head and neck imaging with PET and PET/CT: Artefacts from dental metallic implants.," Eur. J. Nucl. Med. Mol. Imaging 29, 367-370 (2002).
67. G. W. Goerres, D. T. Schmid, and G. K. Eyrich, " Do hardware artefacts influence the performance of head and neck PET scans in patients with oral cavity squamous cell cancer?," Dentomaxillofac Radiol. 32, 365-371 (2003).
68. E. M. Kamel, C. Burger, A. Buck, G. K. von Schulthess, and G. W. Goerres, " Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner.," Eur. Radiol. 13, 724-728 (2003).
69. S. Bujenovic, F. Mannting, R. Chakrabarti, and D. Ladnier, " Artifactual 2-deoxy-2-[(18)F]fluoro-D-glucose localization surrounding metallic objects in a PET/CT scanner using CT-based attenuation correction.," Mol. Imaging Biol. 5, 20-22 (2003).
70. F. P. DiFilippo and R. C. Brunken, " Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET/CT?," J. Nucl. Med. 46, 436-443 (2005).
71. G. W. Goerres, S. I. Ziegler, C. Burger, T. Berthold, G. K. Von Schulthess, and A. Buck, " Artifacts at PET and PET/CT caused by metallic hip prosthetic material.," Radiology 226, 577-584 (2003).
72. A. K. Berthelsen, S. Holm, A. Loft, T. L. Klausen, F. Andersen, and L. Hojgaard, " PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.," Eur. J. Nucl. Med. Mol. Imaging 32, 1167-1175 (2005).
73. C. Cohade, M. Osman, Y. Nakamoto, L. T. Marshall, J. M. Links, E. K. Fishman, and R. L. Wahl, " Initial experience with oral contrast in PET/CT: Phantom and clinical studies.," J. Nucl. Med. 44, 412-416 (2003).
74. M. P. Mac Manus, R. J. Hicks, J. P. Matthews, A. McKenzie, D. Rischin, E. K. Salminen, and D. L. Ball, " Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.," J. Clin. Oncol. 21, 1285-1292 (2003).
75. R. J. Hicks, M. P. Mac Manus, J. P. Matthews, A. Hogg, D. Binns, D. Rischin, D. L. Ball, and L. J. Peters, " Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: Inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.," Int. J. Radiat. Oncol., Biol., Phys. 60, 412-418 (2004).
76. M. Macmanus, I. D'Costa, S. Everitt, J. Andrews, T. Ackerly, D. Binns, E. Lau, D. Ball, L. Weih, and R. J. Hicks, " Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.," Australas. Radiol. 51, 386-393 (2007).
77. J. Brunetti, A. Caggiano, B. Rosenbluth, and C. Vialotti, " Technical aspects of positron emission tomography/computed tomography fusion planning.," Semin Nucl. Med. 38, 129-136 (2008).
78. U. Nestle, S. Kremp, A. Schaefer-Schuler, C. Sebastian-Welsch, D. Hellwig, C. Rube, and C. M. Kirsch, " Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.," J. Nucl. Med. 46, 1342-1348 (2005).
79. T. Pan, O. Mawlawi, D. Luo, H. H. Liu, P. C. Chi, M. V. Mar, G. Gladish, M. Truong, J. Erasmus, Jr., Z. Liao, and H. A. Macapinlac, " Attenuation correction of PET cardiac data with low-dose average CT in PET/CT.," Med. Phys. 33, 3931-3938 (2006).
80. T. Pan, O. Mawlawi, S. A. Nehmeh, Y. E. Erdi, D. Luo, H. H. Liu, R. Castillo, R. Mohan, Z. Liao, and H. A. Macapinlac, " Attenuation correction of PET images with respiration-averaged CT images in PET/CT.," J. Nucl. Med. 46, 1481-1487 (2005).
81. J. A. Nye, F. Esteves, and J. R. Votaw, " Minimizing artifacts resulting from respiratory and cardiac motion by optimization of the transmission scan in cardiac PET/CT.," Med. Phys. 34, 1901-1906 (2007).
82. T. Ishimori, T. Saga, Y. Nagata, Y. Nakamoto, T. Higashi, M. Mamede, T. Mukai, Y. Negoro, T. Aoki, M. Hiraoka, and J. Konishi, " 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.," Ann. Nucl. Med. 18, 669-674 (2004).
83. G. J. Cook, E. A. Wegner, and I. Fogelman, " Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.," Semin Nucl. Med. 34, 122-133 (2004).
84. A. Martinez-Moller, M. Souvatzoglou, N. Navab, M. Schwaiger, and S. G. Nekolla, " Artifacts from misaligned CT in cardiac perfusion PET/CT studies: Frequency, effects, and potential solutions.," J. Nucl. Med. 48, 188-193 (2007).
85. T. Beyer, G. Antoch, S. Muller, T. Egelhof, L. S. Freudenberg, J. Debatin, and A. Bockisch, " Acquisition protocol considerations for combined PET/CT imaging.," J. Nucl. Med., Suppl. 45, 25S-35S (2004).
86. K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, A. Guha, and S. Sdringola, " Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: A definitive analysis of causes, consequences, and corrections.," J. Nucl. Med. 48, 1112-1121 (2007).
87. K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, and S. Sdringola, " Reducing radiation dose in rest-stress cardiac PET/CT by single poststress cine CT for attenuation correction: Quantitative validation.," J. Nucl. Med. (in press).
88. P. C. Chi, O. Mawlawi, S. A. Nehmeh, Y. E. Erdi, P. A. Balter, D. Luo, R. Mohan, and T. Pan, " Design of respiration averaged CT for attenuation correction of the PET data from PET/CT.," Med. Phys. 34, 2039-2047 (2007).
89. M. M. Osman, C. Cohade, Y. Nakamoto, L. T. Marshall, J. P. Leal, and R. L. Wahl, " Clinically significant inaccurate localization of lesions with PET/CT: Frequency in 300 patients.," J. Nucl. Med. 44, 240-243 (2003).
90. P. M. Chi, O. Mawlawi, D. Luo, Z. Liao, H. A. Macapinlac, and T. Pan, " Effects of respiration-averaged CT on PET/CT quantification and its potential impact on GTV delineation.," Int. J. Radiat. Oncol., Biol., Phys. (accepted).
91. D. W. Townsend, " A combined PET/CT scanner: The choices.," J. Nucl. Med. 42, 533-534 (2001).
92. D. W. Townsend, " Physical principles and technology of clinical PET imaging.," Ann. Acad. Med. Singapore 33, 133-145 (2004).
93. D. W. Townsend, T. Beyer, and T. M. Blodgett, " PET/CT scanners: A hardware approach to image fusion.," Semin Nucl. Med. 33, 193-204 (2003).
94. D. W. Townsend, J. P. Carney, J. T. Yap, and N. C. Hall, " PET/CT today and tomorrow.," J. Nucl. Med., Suppl. 45, 4S-14S (2004).
95. D. W. Townsend and S. R. Cherry, " Combining anatomy and function: The path to true image fusion.," Eur. Radiol. 11, 1968-1974 (2001).
96. S. R. Cherry, " The 2006 Henry N. Wagner lecture: Of mice and men (and positrons)-Advances in PET imaging technology.," J. Nucl. Med. 47, 1735-1745 (2006).
97. T. M. Blodgett, C. C. Meltzer, and D. W. Townsend, " PET/CT: Form and function.," Radiology 242, 360-385 (2007).
98. J. R. Stickel and S. R. Cherry, " High-resolution PET detector design: modelling components of intrinsic spatial resolution.," Phys. Med. Biol. 50, 179-195 (2005).
99. O. Mawlawi, D. A. Podoloff, S. Kohlmyer, J. J. Williams, C. W. Stearns, R. F. Culp, and H. Macapinlac, " Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes.," J. Nucl. Med. 45, 1734-1742 (2004).
100. S. Surti, A. Kuhn, M. E. Werner, A. E. Perkins, J. Kolthammer, and J. S. Karp, " Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities.," J. Nucl. Med. 48, 471-480 (2007).
101. P. E. Kinahan and J. S. Karp, " Figures of merit for comparing reconstruction algorithms with a volume-imaging PET scanner.," Phys. Med. Biol. 39, 631-642 (1994).
102. R. Leahy and C. Byrne, " Recent developments in iterative image reconstruction for PET and SPECT.," IEEE Trans. Med. Imaging 19, 257-260 (2000).
103. V. Bettinardi, P. Mancosu, M. Danna, G. Giovacchini, C. Landoni, M. Picchio, M. C. Gilardi, A. Savi, I. Castiglioni, M. Lecchi, and F. Fazio, " Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: A discovery-STE phantom and patient study.," Q. J. Nucl. Med. Mol. Imaging 51, 214-223 (2007).
104. E. J. Hoffman, M. E. Phelps, G. Wisenberg, H. R. Schelbert, and D. E. Kuhl, " Electrocardiographic gating in positron emission computed tomography.," J. Comput. Assist. Tomogr. 3, 733-739 (1979).
105. S. A. Nehmeh, Y. E. Erdi, C. C. Ling, K. E. Rosenzweig, H. Schoder, S. M. Larson, H. A. Macapinlac, O. D. Squire, and J. L. Humm, " Effect of respiratory gating on quantifying PET images of lung cancer.," J. Nucl. Med. 43, 876-881 (2002).
106. S. A. Nehmeh, Y. E. Erdi, C. C. Ling, K. E. Rosenzweig, O. D. Squire, L. E. Braban, E. Ford, K. Sidhu, G. S. Mageras, S. M. Larson, and J. L. Humm, " Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer.," Med. Phys. 29, 366-371 (2002).
107. S. A. Nehmeh, Y. E. Erdi, K. E. Rosenzweig, H. Schoder, S. M. Larson, O. D. Squire, and J. L. Humm, " Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: Methodology and comparison with respiratory gated PET.," J. Nucl. Med. 44, 1644-1648 (2003).
108. S. A. Nehmeh, " Four-dimensional (4D) PET/CT imaging of the thorax.," Med. Phys. 31, 3179-3186 (2004).
109. P. E. Kinahan, H. Vesselle, L. MacDonald, A. M. Alessio, S. Kohlmyer, and T. Lewellen, " Whole-body respiratory gated PET/CT.," J. Nucl. Med. Meeting Abstracts, May 2006; 47, 187P.
110. O. Mawlawi, T. Pan, and H. A. Macapinlac, " PET/CT imaging techniques, considerations, and artifacts.," J. Thorac. Imaging 21, 99-110 (2006).
111. J. L. Garcia-Ramirez, S. Mutic, J. F. Dempsey, D. A. Low, and J. A. Purdy, " Performance evaluation of an 85-cm -bore x-ray computed tomography scanner designed for radiation oncology and comparison with current diagnostic CT scanners.," Int. J. Radiat. Oncol., Biol., Phys. 52, 1123-1131 (2002).
112. T. Beyer, A. Bockisch, H. Kuhl, and M. J. Martinez, " Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.," J. Nucl. Med. 47, 91-99 (2006).
113. J. S. Maltz, S. Bose, H. P. Shukla, and A. R. Bani-Hashemi, " CT truncation artifact removal using water-equivalent thicknesses derived from truncated projection data.," Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007, 2907-2911 (2007).
114. O. Mawlawi, J. J. Erasmus, T. Pan, D. D. Cody, R. Campbell, A. H. Lonn, S. Kohlmyer, H. A. Macapinlac, and D. A. Podoloff, " Truncation artifact on PET/CT: Impact on measurements of activity concentration and assessment of a correction algorithm.," AJR, Am. J. Roentgenol. 186, 1458-1467 (2006).
115. K. R. Britton, G. Starkschall, S. L. Tucker, T. Pan, C. Nelson, J. Y. Chang, J. D. Cox, R. Mohan, and R. Komaki, " Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography.," Int. J. Radiat. Oncol., Biol., Phys. (in press).
116. W. V. Vogel, J. A. van Dalen, B. Wiering, H. Huisman, F. H. Corstens, T. J. Ruers, and W. J. Oyen, " Evaluation of image registration in PET/CT of the liver and recommendations for optimized imaging.," J. Nucl. Med. 48, 910-919 (2007).
117. M. M. Osman, C. Cohade, Y. Nakamoto, and R. L. Wahl, " Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT.," Eur. J. Nucl. Med. Mol. Imaging 30, 603-606 (2003).
118. G. W. Goerres, E. Kamel, B. Seifert, C. Burger, A. Buck, T. F. Hany, and G. K. Von Schulthess, " Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system.," J. Nucl. Med. 43, 1469-1475 (2002).
119. G. W. Goerres, E. Kamel, T. N. Heidelberg, M. R. Schwitter, C. Burger, and G. K. von Schulthess, " PET-CT image co-registration in the thorax: influence of respiration.," Eur. J. Nucl. Med. Mol. Imaging 29, 351-360 (2002).
120. C. B. Caldwell, K. Mah, M. Skinner, and C. E. Danjoux, " Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET.," Int. J. Radiat. Oncol., Biol., Phys. 55, 1381-1393 (2003).
121. P. J. Keall, " The management of respiratory motion in radiation oncology report of AAPM Task Group 76.," Med. Phys. 33, 3874-3900 (2006).
122. D. A. Low, " A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing.," Med. Phys. 30, 1254-1263 (2003).
123. T. Pan, T. Y. Lee, E. Rietzel, and G. T. Chen, " 4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT.," Med. Phys. 31, 333-340 (2004).
124. P. J. Keall, G. Starkschall, H. Shukla, K. M. Forster, V. Ortiz, C. W. Stevens, S. S. Vedam, R. George, T. Guerrero, and R. Mohan, " Acquiring 4D thoracic CT scans using a multislice helical method.," Phys. Med. Biol. 49, 2053-2067 (2004).
125. T. Pan, X. Sun, and D. Luo, " Improvement of the cine-CT based 4D-CT imaging.," Med. Phys. 34, 4499-4503 (2007).
126. M. A. Admiraal, D. Schuring, and C. W. Hurkmans, " Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.," Radiother. Oncol. 86, 55-60 (2008).
127. R. W. Underberg, F. J. Lagerwaard, B. J. Slotman, J. P. Cuijpers, and S. Senan, " Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer.," Int. J. Radiat. Oncol., Biol., Phys. 63, 253-260 (2005).
128. J. D. Bradley, A. N. Nofal, I. M. El Naqa, W. Lu, J. Liu, J. Hubenschmidt, D. A. Low, R. E. Drzymala, and D. Khullar, " Comparison of helical, maximum intensity projection (MIP), and averaged intensity (AI) 4D CT imaging for stereotactic body radiation therapy (SBRT) planning in lung cancer.," Radiother. Oncol. 81, 264-268 (2006).
129. A. C. Riegel, J. Y. Chang, S. S. Vedam, V. Johnson, P. M. Chi, and T. Pan, " Cine CT without a respiratory surrogate in planning of stereotactic radiotherapy for non-small cell lung cancer.," Int. J. Radiat. Oncol., Biol., Phys. (in press).
130. K. J. Biehl, F. M. Kong, F. Dehdashti, J. Y. Jin, S. Mutic, I. El Naqa, B. A. Siegel, and J. D. Bradley, " 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: Is a single standardized uptake value threshold approach appropriate?," J. Nucl. Med. 47, 1808-1812 (2006).
131. T. Pan, " Comparison of helical and cine acquisitions for 4D-CT imaging with multislice CT.," Med. Phys. 32, 627-634 (2005).
132. Y. E. Erdi, " The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.," J. Nucl. Med. 45, 1287-1292 (2004).
133. S. A. Nehmeh, " Quantitation of respiratory motion during 4D-PET/CT acquisition.," Med. Phys. 31, 1333-1338 (2004).
134. C. C. Nagel, G. Bosmans, A. L. Dekker, M. C. Ollers, D. K. De Ruysscher, P. Lambin, A. W. Minken, N. Lang, and K. P. Schafers, " Phased attenuation correction in respiration correlated computed tomography/positron emitted tomography.," Med. Phys. 33, 1840-1847 (2006).
135. A. C. Paulino and P. A. Johnstone, " FDG-PET in radiotherapy treatment planning: Pandora's box?," Int. J. Radiat. Oncol., Biol., Phys. 59, 4-5 (2004).
136. Y. E. Erdi, O. Mawlawi, S. M. Larson, M. Imbriaco, H. Yeung, R. Finn, and J. L. Humm, " Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding.," Cancer 80, 2505-2509 (1997).
137. T. R. Miller and P. W. Grigsby, " Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.," Int. J. Radiat. Oncol., Biol., Phys. 53, 353-359 (2002).
138. J. D. Kiffer, S. U. Berlangieri, A. M. Scott, G. Quong, M. Feigen, W. Schumer, C. P. Clarke, S. R. Knight, and F. J. Daniel, " The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer.," Lung Cancer 19, 167-177 (1998).
139. S. Beaulieu, P. Kinahan, J. Tseng, L. K. Dunnwald, E. K. Schubert, P. Pham, B. Lewellen, and D. A. Mankoff, " SUV varies with time after injection in (18)F-FDG PET of breast cancer: Characterization and method to adjust for time differences.," J. Nucl. Med. 44, 1044-1050 (2003).
140. L. M. Hamberg, G. J. Hunter, N. M. Alpert, N. C. Choi, J. W. Babich, and A. J. Fischman, " The dose uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification?," J. Nucl. Med. 35, 1308-1312 (1994).